Hap Trading, LLC Acelrx Pharmaceuticals Inc Call Options Transaction History

Hap Trading, LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 12, 2022	SELL	$0.18 - $0.29 $306 - $492	-1,700 Reduced 6.16%	25,900 $0
Q1 2022 May 12, 2022	SELL	$0.28 - $0.61 $1,232 - $2,684	-4,400 Reduced 13.75%	27,600 $0
Q4 2021 Feb 14, 2022	BUY	$0.49 - $1.02 $3,675 - $7,650	7,500 Added 30.61%	32,000 $1,000
Q3 2021 Nov 10, 2021	BUY	$0.93 - $1.51 $3,441 - $5,587	3,700 Added 17.79%	24,500 $3,000
Q2 2021 Aug 11, 2021	BUY	$1.03 - $1.7 $21,424 - $35,360	20,800 New	20,800 $1,000
Q4 2020 Feb 16, 2021	SELL	$1.18 - $1.98 $24,190 - $40,590	-20,500 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$1.01 - $1.81 $20,705 - $37,105	20,500 New	20,500 $2,000
Q1 2019 May 10, 2019	SELL	$2.35 - $3.83 $235,000 - $383,000	-100,000 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$2.13 - $4.8 $213,000 - $480,000	100,000 New	100,000 $0

Ticker ACRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 7,366,600
Market Cap $8.32M
Description
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.